Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CCL24, also known as eotaxin-2, is a small secreted cytokine belonging to the CC chemokine family. It acts primarily as a chemoattractant, strongly inducing migration of eosinophils via interaction with the CCR3 receptor. It is involved in immunoregulatory and inflammatory processes and is implicated in diseases such as asthma, atopic dermatitis, and primary sclerosing cholangitis. Therapeutic targeting of CCL24 or its pathway is being explored for various immune-mediated disorders.
Targets CCL24 axis
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-C motif chemokine ligand 24 (CCL24).